The Evoque Tricuspid Valve Replacement System (Edwards Lifesciences Corp.) is indicated for the improvement of health status in patients with symptomatic severe tricuspid regurgitation despite optimal medical therapy, for whom tricuspid valve replacement is deemed appropriate by a heart team.
